Back

Diasip

Features
  • Suitable as a sole source of nutrition.^
  • Suitable for oral or enteral use: can be consumed orally or delivered via an enteral feeding tube.
  • Unique low glycaemic index carbohydrate blend: isomaltulose and slowly digestible starch to improve the postprandial plasma glucose response.1-4
  • Optimal macronutrient ratio: to improve glycaemic control and meet international diabetes and chronic disease guidelines.5-7
  • Fibre enriched (5g/bottle): to help improve glucose metabolism.8
  • User-friendly bottle: ergonomic plastic bottle, with resealable easy to open cap.

Product Information

A ready-to-drink, nutritionally complete, low glycaemic index oral nutritional supplement.

Link copied!
Indications

For the dietary management of disease related malnutrition in patients with diabetes mellitus, hyperglycaemia or impaired glucose tolerance.

Important Notice
  • Not for parenteral use.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with fructosaemia.
  • Not suitable for patients requiring a fibre free diet.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants and children under 3 years of age.
  • Use with caution in children aged 3-6 years of age.
  • Must be used under medical supervision.
Direction for Use
  • Shake well before use.
  • Best served chilled.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, close the bottle and store in a refrigerator.
  • Discard unused content after 24 hours.
Order Information

Contact Nutricia Customer Experience 1800 889 480

Diasip  Presentation  Product Code  Units per carton 
Vanilla  200ml bottle  169349 24 
Ingredients

Full ingredients list and nutritional information is available on the product fact sheet.

Allergen & Cultural Information
  • Contains: milk, soy and fish.
  • Halal certified.
  • Nutricia UK and/or Ireland have Kosher approval for this product.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
References
  1. Hofman Z, Rouws C, van Drunen JDE, Kuipers H. The effect of enteral nutrition on glucose and triglyceride concentrations during 6 hours continuous feeding in diabetic patients. Clin Nutr. 2004;23:1478-79.
  2. Kawai K, Yoshikawa H, Murayama Y, Yamashita K. Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res. 1989;21:338-40.
  3. Kawai K, Okuda Y, Yamashita K. Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol Jpn. 1985;32:933-6.
  4. Severijnen C, van der Beek EM, Hageman R, van Laere K, Van de Heijning BJM. Amelioration of fasting plasma glucose levels in diabetic rats after two weeks on an aspartate-rich diet. 2007 25th International Symposium on Diabetes and Nutrition (DNSG).
  5. American Diabetes Association (ADA). Standards of medical care in diabetes. Diab. Care. 2006;29:4-73.
  6. DNSG: The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), 1999. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr. 2000;54:353-355.
  7. National Health and Medical Research Council. Australian Dietary Guidelines. 2013. Canberra: National Health and Medical Research Council.
  8. Higgins JA. Resistant starch: metabolic effects and potential health benefits. J AOAC Int. 2004;87:761-8
Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5.

 
Food for special medical purposes for use under medical supervision.